Pharmacokinetics is the study of the becoming of a drug candidate in the organism by the analysis of the evolution of plasmatic concentration over time. It depends of the physiochemical characteristics of the drug candidate and is characterized by 4 steps (ADME) = Absorption, Distribution, Metabolization and Elimination.

The distribution of the compound, since the blood towards the targeted organs for its principal activity or towards other tissues or organs, which can bring to the apparition of undesirable effects, is notably determined by the measure of the compound in the different organs at a given time.

The pharmacokinetics settings of a drug determinates its posology, but also the choice of the route recommended by the administration and the most appropriated galenic form.

Pharmacokinetics settings of the absorption

– Maximal concentration of the principal asset in the vascular compartment (C max)

– Necessary time of the principal asset for the reaching of the maximal concentration (T max)

– Kidney clearance (capacity of the kidney to extract the drug and/or its metabolites of the blood volume)

– Half-life (how much time for the reduction of 50% of the principal asset plasmatic concentration)

Protocol

SpeciesMouse, rat
Root of the administrationIV, PO, SC, IP, IN
SamplesPlasma and organ if necessary
Analysis methodLC-MS/MS
Data deliveryPharmacokinetics settings 
Replicate3

 

Data

t 1/2 (min)

87±3

Cmax (μM)

15

Tmax (min)

34±2

Vz/F (mL/kg)

41±2

AUC last PO (min.ng/mL)

2017±224

Cl/F (mL/min/kg)

  703835±33809    

Notes

The number and time of the samples can be personalized as well as the organs to be removed.

The pharmacokinetics will be dependent on the route of administration, the formulation and the species.

The dose and formulation to be administered will be defined by the client.